Table 1.
Fixed combination latanoprost/timolol (n = 163) | Unfixed combination brimonidine/timolol (n = 162) | |
Sex, n (%) | ||
Male | 73 (44.8) | 73 (45.1) |
Female | 90 (55.2) | 89 (54.9) |
Age (years) | ||
Mean | 65.5 | 65.1 |
SD | 10.30 | 11.56 |
Range | 33–91 | 23–87 |
Ethnic origin, n (%) | ||
White | 158 (96.9) | 160 (98.8) |
Black | 0 (0.0) | 1 (0.6) |
Hispanic | 4 (2.5) | 1 (0.6) |
Other | 1 (0.6) | 0 (0.0) |
Eye colour of study eye(s), n (%) | ||
Homogeneously blue, grey or green | 48 (29.4) | 48 (29.6) |
Homogeneously brown | 85 (52.1) | 88 (54.3) |
Blue-brown/grey-brown | 19 (11.7) | 14 (8.6) |
Green-brown | 8 (4.9) | 6 (3.7) |
Yellow-brown | 3 (1.8) | 6 (3.7) |
Study eye(s), n (%) | ||
Right | 41 (25.2) | 34 (21.0) |
Left | 33 (20.2) | 31 (19.1) |
Both | 89 (54.6) | 97 (59.9) |
Treated eye(s), n (%) | ||
Right | 27 (16.6) | 26 (16.0) |
Left | 37 (22.7) | 30 (18.5) |
Both | 99 (60.7) | 106 (65.4) |
Diagnosis of study eye(s), n (%) | ||
Primary open angle glaucoma | 119 (73.0) | 111 (68.5) |
Ocular hypertension | 37 (22.7) | 43 (26.5) |
Other specifications | 4 (2.5) | 7 (4.3) |
Mixed* | 3 (1.8) | 1 (0.6) |
Duration of condition (study eye) | ||
<6 months | 11 (6.7) | 6 (3.7) |
6 to<36 months | 51 (31.3) | 51 (31.5) |
36 to<120 months | 78 (47.9) | 75 (46.3) |
⩾120 months | 23 (14.1) | 30 (18.5) |
*Different diagnosis in right and left eyes.
SD, standard deviation.